Cryo-Cell International Income Statement

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Revenue	31.57	31.99	31.34	30.34	28.88
Revenue Growth (YoY)	-1.31%	2.05%	3.32%	5.03%	-7.26%
Cost of Revenue	11.74	7.95	12.13	8.79	10.15
Gross Profit	19.83	24.04	19.22	21.54	18.73
Selling, General & Admin	18.22	18.52	17.17	15.58	14.61
Research & Development	0.38	1.24	1.17	0.38	0.05
Operating Expenses	19.35	20.25	19.46	17.08	15.49
Operating Income	0.48	3.79	-0.25	4.46	3.24
Interest Expense	-2.07	-1.86	-1.24	-1.08	-1.38
Interest & Investment Income	-	0.11	0.12	-	-
Other Non Operating Income (Expenses)	0.05	0.01	0	0	0
EBT Excluding Unusual Items	-1.53	2.04	-1.36	3.39	1.86
Gain (Loss) on Sale of Investments	-0.81	0.77	0.05	-0.04	-0.01
Gain (Loss) on Sale of Assets	-	-	-	0.41	-0.02
Asset Writedown	-	-	-13.11	-	-
Other Unusual Items	-	-0	1.05	-0.44	0.78
Pretax Income	-2.34	2.8	-13.36	3.32	2.61
Income Tax Expense	0.09	2.4	-3.84	0.55	0.53
Net Income	-2.43	0.4	-9.52	2.77	2.08
Net Income to Common	-2.43	0.4	-9.52	2.77	2.08
Net Income Growth	-	-	-	33.02%	-42.52%
Shares Outstanding (Basic)	8	8	8	8	8
Shares Outstanding (Diluted)	8	8	8	8	8
Shares Change (YoY)	-1.75%	-1.54%	-1.69%	1.46%	2.72%
EPS (Basic)	-0.30	0.05	-1.14	0.33	0.26
EPS (Diluted)	-0.30	0.05	-1.14	0.33	0.25
EPS Growth	-	-	-	30.95%	-44.44%
Free Cash Flow	5.25	3.61	2.08	-3.6	6.09
Free Cash Flow Per Share	0.65	0.44	0.25	-0.42	0.73
Dividend Per Share	-	0.250	-	-	-
Gross Margin	62.82%	75.15%	61.31%	71.02%	64.85%
Operating Margin	1.53%	11.85%	-0.79%	14.70%	11.20%
Profit Margin	-7.70%	1.26%	-30.38%	9.13%	7.21%
Free Cash Flow Margin	16.63%	11.28%	6.64%	-11.85%	21.09%
EBITDA	1.47	4.48	1.15	5.96	4.27
EBITDA Margin	4.65%	14.02%	3.68%	19.64%	14.80%
D&A For EBITDA	0.99	0.69	1.4	1.5	1.04
EBIT	0.48	3.79	-0.25	4.46	3.24
EBIT Margin	1.53%	11.85%	-0.79%	14.70%	11.20%
Effective Tax Rate	-	85.66%	-	16.50%	20.21%
Revenue as Reported	31.57	31.99	31.34	30.34	28.88
Advertising Expenses	-	1.07	0.95	0.76	0.84

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q